Related Experiment Video

Updated: Sep 10, 2025

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.2K

Aptamer-conjugation targets decoy-ODN-therapeutics to liver fibrosis

Larissa W Picard1, Ziwen Jiang1

  • 1Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, TX 75080, USA.

Molecular Therapy. Nucleic Acids
|August 21, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

1.9K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

1.9K

Related Experiment Videos

Last Updated: Sep 10, 2025

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.2K
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

1.9K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

1.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

Articles linked to this work by shared authors, journal, and citation graph.

AI-driven financial risk management in complex mobile economies: a contextual-technology fit and security reassurance model.

Frontiers in artificial intelligence·2026

Clotrimazole-loaded PLGA microparticles for local drug delivery to the vagina: Shape does matter.

Animal models and experimental medicine·2026

Retraction notice to "A study on participatory experiences in cultural and tourism commercial spaces" [Heliyon 10 (2024) e24632].

Heliyon·2025

The positive correlation between parity and overactive bladder in American adults: the mediating effect of body mass index.

BMC public health·2025

Self-targeting carrier-free coordination nanotherapeutics for tumor microenvironment modulation and enhanced chemo-dynamic oncotherapy.

Colloids and surfaces. B, Biointerfaces·2025

Ruthenium-quercetin coordinated nanotherapeutics with macrophage polarization regulation to rapidly promote bacterial-infected wound healing.

Materials today. Bio·2025

Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells.

Molecular therapy. Nucleic acids·2026

An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen.

Molecular therapy. Nucleic acids·2026

Functional analysis of TTN uORFs reveals context-dependent translational regulation.

Molecular therapy. Nucleic acids·2026

Gene therapy for hereditary hematological disorders: From clinical breakthroughs to future horizons.

Molecular therapy. Nucleic acids·2026

To scramble or not: Steric blocking 2'-MOE/PS control antisense oligonucleotides across cellular models.

Molecular therapy. Nucleic acids·2026

PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.

Molecular therapy. Nucleic acids·2026

Transvaginal in-bag directional morcellation with endometrial preservation for large uteri: an initial clinical feasibility study.

Frontiers in medicine·2026

Distinct structural mechanisms drive gain-of-function activation of TMEM16E in gnathodiaphyseal dysplasia.

Research square·2026

mTOR disrupts cerebrovascular RNA regulatory networks in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026

PERM1 Gene Therapy Prevents Pressure Overload-induced Heart Failure Through a Sarcomere-Mitochondria Energetic Microdomain.

Research square·2026

Self-adjuvanting Ebola virus-like particles that incorporate a cellular interferon-inducing domain.

Research square·2026

Surgically Modifiable Insertion Geometry Drives Thrombogenic Flow in the Modified Blalock-Taussig-Thomas Shunt.

medRxiv : the preprint server for health sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us